Bristol-Myers Squibb Company (BMYMP)

OTCMKTS · Delayed Price · Currency is USD · Preferred Stock
801.01
-73.99 (-8.46%)
Apr 24, 2025, 11:01 AM EDT
0.13%
Market Cap 120.95B
Revenue (ttm) 48.30B
Net Income (ttm) -8.95B
Shares Out n/a
EPS (ttm) -4.41
PE Ratio n/a
Forward PE n/a
Dividend 2.00 (0.25%)
Ex-Dividend Date May 6, 2025
Volume 3
Average Volume 1
Open 805.00
Previous Close 875.00
Day's Range 801.01 - 805.00
52-Week Range 701.00 - 1,225.00
Beta n/a
RSI 32.12
Earnings Date Apr 24, 2025

About BMYMP

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Industry Pharmaceutical Preparations
Founded 1887
Employees 34,100
Stock Exchange OTCMKTS
Ticker Symbol BMYMP
Full Company Profile

News

There is no news available yet.